Clinical Trials Browser

Phase 1/2 × Has results × Solid Tumors × Clear all

NCT02240238 2025-01-22

Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer

Phase 1/2 Completed

119 enrolled 24 charts

Other solid neoplasm

Solid Tumors

NCT02598960 2023-03-06

An Investigational Immuno-therapy Study of Experimental Medication BMS-986156, Given by Itself or in Combination With Nivolumab in Patients With Solid Cancers or Cancers That Have Spread.

Phase 1/2 Completed

295 enrolled 28 charts

Other solid neoplasm

Solid Tumors

NCT02593786 2022-10-24

CheckMate 077

Phase 1/2 Completed

58 enrolled 31 charts

Other solid neoplasm

Solid Tumors

NCT02639546 2022-09-16

iMATRIXcobi

Phase 1/2 Completed

56 enrolled 31 charts

Other solid neoplasm

Solid Tumors

NCT02587962 2021-01-14

Dose-escalation Study of Birinapant and Pembrolizumab in Solid Tumors

Phase 1/2 Terminated

34 enrolled 27 charts

Other solid neoplasm

Solid Tumors